Qualigen Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2014 to Q3 2024.
  • Qualigen Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.79M, a 50.9% increase year-over-year.
  • Qualigen Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.85M, a 54.7% increase year-over-year.
  • Qualigen Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$13.4M, a 28% increase from 2022.
  • Qualigen Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$18.6M, a 4.15% decline from 2021.
  • Qualigen Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.9M, a 12.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.85M -$1.79M +$1.86M +50.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$9.72M -$1.58M +$1.89M +54.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$11.6M -$2.03M +$1.81M +47.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-02
Q4 2023 -$13.4M -$2.45M +$3.92M +61.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-08
Q3 2023 -$17.3M -$3.66M +$169K +4.41% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$17.5M -$3.46M +$659K +16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$18.2M -$3.85M +$474K +11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-02
Q4 2022 -$18.6M -$6.37M -$2.15M -51% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 -$16.5M -$3.83M -$788K -25.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$15.7M -$4.12M +$1.27M +23.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$17M -$4.32M +$923K +17.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$17.9M -$4.22M -$11.4M -159% Oct 1, 2021 Dec 31, 2021 10-K 2023-05-02
Q3 2021 -$6.54M -$3.04M +$5.08M +62.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$11.6M -$5.4M +$13.2M +70.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$24.8M -$5.24M -$4.37M -501% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$20.4M $7.14M +$11.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$32M -$8.11M -$7.76M -2178% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$24.3M -$18.6M -$18M -3025% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$6.3M -$873K +$3.83M +81.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$10.1M -$4.48M +$2.15M +32.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-31
Q3 2019 -$12.3M -$356K +$4.29M +92.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$16.6M -$595K +$2.99M +83.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$19.6M -$4.71M -$2.69M -134% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$16.9M -$6.63M -$4.41M -199% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 -$12.5M -$4.65M -$2.64M -131% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$9.82M -$3.58M -$1.62M -82.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$8.2M -$2.01M -$339K -20.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$7.86M -$2.22M +$5.37M +70.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$13.2M -$2.01M +$1.52M +43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$14.8M -$1.96M +$2.18M +52.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$16.9M -$1.67M +$1.46M +46.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$18.4M -$7.59M -$5.37M -241% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$13M -$3.53M -$446K -14.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$12.6M -$4.14M -$2.04M -97.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$10.5M -$3.13M -$1.74M -126% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$8.79M -$2.22M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 -$3.08M -$2.81M -1056% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$2.1M -$1.71M -436% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$1.39M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 -$266K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$391K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.